Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学CancerSEEK Liquid Biopsy, Multi-Cancer Early Detection

Bert Vogelstein

MD

🏢Johns Hopkins University🌐USA

Clayton Professor (cfDNA context)

104
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Bert Vogelstein and Kenneth Kinzler developed CancerSEEK — a multi-cancer early detection blood test combining cfDNA mutation analysis with protein biomarkers for simultaneous screening of multiple cancer types. This approach exemplifies the multi-cancer early detection (MCED) concept now being clinically tested (Galleri, other MCED tests) — potentially enabling annual blood tests that detect cancers before symptoms, transforming cancer screening for cancers without current screening tests.

Share:

🧪Research Fields 研究领域

CancerSEEK multi-cancer blood test
cfDNA protein biomarker combination
early detection cancer blood test
multi-cancer early detection MCED
Galleri blood test early detection

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Bert Vogelstein 的研究动态

Follow Bert Vogelstein's research updates

留下邮箱,当我们发布与 Bert Vogelstein(Johns Hopkins University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment